September 7, 2021 -- Emulate has secured $82 million in a series E financing round led by existing investor Northpond Ventures.
Perceptive Advisors also participated in the funding round. Emulate will use the funds to expand R&D and scale its commercial organization to support a global customer base for its organ-on-a-chip technology, according to the company. Emulate has raised a total of $225 million.